Cohort Dashboard
GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated quarterly.
Total Global Data
0
Unique Locations
0
Cohorts
0
Samples Expected
0
Samples Completed
Last Updated: September 9, 2021 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova
Showing 50 of 192 cohort studies.
ADepT-PD
University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 408 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 408 Expected
AGPDS
QIMR Berghofer Medical Research Institute | Brisbane, Australia
Number of Samples Completed and Expected
Case Samples
0 Completed out of 5,000 Expected
Control Samples
0 Completed out of 5,000 Expected
Total Samples
0 Completed out of 10,000 Expected
ANANEOS
Ionian University, Altoida Inc. | Corfu, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 300 Expected
Control Samples
0 Completed out of 300 Expected
Total Samples
0 Completed out of 600 Expected
Arizona Brain Bank Brain and body donation programme (BBDP)
Banner Sun Health Research Institution | Pheonix, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 324 Expected
Control Samples
0 Completed out of 100 Expected
Total Samples
0 Completed out of 424 Expected
BADGE-PD
Assistance Publique Hôspitaux de Paris | Paris, France
Number of Samples Completed and Expected
Case Samples
0 Completed out of 304 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 304 Expected
Baylor College of Medicine (BCM)
Baylor College of Medicine | Houston, United States
Access Data on AMP® PDNumber of Samples Completed and Expected
Case Samples
533 Completed out of 553 Expected
Control Samples
246 Completed out of 255 Expected
Total Samples
779 Completed out of 808 Expected
Ancestry Breakdown for Samples Completed
ShowBCM-UMD
University of Maryland | College Park, United States
Access Data on AMP® PDNumber of Samples Completed and Expected
Case Samples
358 Completed out of 358 Expected
Control Samples
83 Completed out of 83 Expected
Total Samples
441 Completed out of 441 Expected
Ancestry Breakdown for Samples Completed
ShowBioFIND
Michael J. Fox Foundation | New York City, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 220 Expected
Control Samples
0 Completed out of 100 Expected
Total Samples
0 Completed out of 320 Expected
Biological markers in PD
National and Kapodistrian University of Athens | Athens, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 350 Expected
Control Samples
0 Completed out of 150 Expected
Total Samples
0 Completed out of 500 Expected
BLAAC-PD – Kaiser Permanente
Kaiser Permanente | Rockville, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 125 Expected
Control Samples
0 Completed out of 125 Expected
Total Samples
0 Completed out of 250 Expected
BLAAC-PD – Rush University
Rush University | Chicago, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 100 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 100 Expected
BLAAC-PD – University of Alabama at Birmingham
University of Alabama at Birmingham | Birmingham, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 50 Expected
Control Samples
0 Completed out of 50 Expected
Total Samples
0 Completed out of 100 Expected
BLAAC-PD – University of Chicago
University of Chicago | Chicago, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 100 Expected
Control Samples
0 Completed out of 50 Expected
Total Samples
0 Completed out of 150 Expected
C-OPD
University of Calgary/McGill University | Calgary, Canada
Number of Samples Completed and Expected
Case Samples
0 Completed out of 1,500 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 1,500 Expected
CALYPSO
University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 400 Expected
Control Samples
0 Completed out of 200 Expected
Total Samples
0 Completed out of 600 Expected
Cambridge Parkinson’s Research Clinic
University of Cambridge | Cambridge, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 250 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 250 Expected
CamPaIGN
University of Cambridge | Cambridge, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 142 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 142 Expected
CANDAS
University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 244 Expected
Control Samples
0 Completed out of 18 Expected
Total Samples
0 Completed out of 262 Expected
Central Asian and Transcaucasian PD (CAT-PD)
University College London | Almaty, Kazakhstan
Number of Samples Completed and Expected
Case Samples
0 Completed out of 200 Expected
Control Samples
0 Completed out of 200 Expected
Total Samples
0 Completed out of 400 Expected
Central Asian and Transcaucasian PD (CAT-PD) – Avicena Tajik State Medical University
Avicena Tajik State Medical University | Dushanbe, Tajikistan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Central Asian and Transcaucasian PD (CAT-PD) – Istanbul Klinic
Istanbul Klinic | Baku, Azerbaijan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Central Asian and Transcaucasian PD (CAT-PD) – Kazakh National Medical University
Kazakh National Medical University | Almaty, Kazakhstan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Central Asian and Transcaucasian PD (CAT-PD) – Somnus Movement Disorders Clinic
Somnus Movement Disorders Clinic | Yerevan, Armenia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Central Asian and Transcaucasian PD (CAT-PD) – Tbilisi State Medical University
Tbilisi State Medical University | Tbilisi, Georgia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Central Asian and Transcaucasian PD (CAT-PD) -South Kazakhstan Medical Academy
South Kazakhstan Medical Academy | Shymkent, Kazakhstan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Christchurch Longitudinal Parkinson’s Study
Southern Health and Disability Ethics Committee | Larissa, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 350 Expected
Control Samples
0 Completed out of 80 Expected
Total Samples
0 Completed out of 430 Expected
Clinical and genetic study of Unusual/Familial Movement Disorders
University of Cincinnati | Cincinnati, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 500 Expected
Control Samples
0 Completed out of 180 Expected
Total Samples
0 Completed out of 680 Expected
Clinicogenetic study of PD in Tunisia
National Institute of Neurology Mongi-Ben Hamida | Tunis, Tunisia
Number of Samples Completed and Expected
Case Samples
0 Completed out of 150 Expected
Control Samples
0 Completed out of 150 Expected
Total Samples
0 Completed out of 300 Expected
CORIELL
CORIELL | Camden, United States
Access Data on AMP® PDNumber of Samples Completed and Expected
Case Samples
4,151 Completed out of 4,478 Expected
Control Samples
2,883 Completed out of 4,111 Expected
Total Samples
7,034 Completed out of 8,589 Expected
Ancestry Breakdown for Samples Completed
ShowCSF Biomarkers
University of Perugia | Perugia, Italy
Number of Samples Completed and Expected
Case Samples
0 Completed out of 60 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 60 Expected
DATATOP
Michael J. Fox Foundation | Rochester, United States
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
DeNoPa
University of Göttingen | Goettingen, Germany
Number of Samples Completed and Expected
Case Samples
0 Completed out of 140 Expected
Control Samples
0 Completed out of 100 Expected
Total Samples
0 Completed out of 240 Expected
DIGPD
Assistance Publique Hôspitaux de Paris | Paris, France
Number of Samples Completed and Expected
Case Samples
0 Completed out of 400 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 400 Expected
ELPD Project
Queen Mary University London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 300 Expected
Control Samples
0 Completed out of 250 Expected
Total Samples
0 Completed out of 550 Expected
Familial and early-onset PD Database
University "Magna Graecia" of Catanzaro | Catanzaro, Italy
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Families with neurodegenerative diseases
Medical University of Vienna | Vienna, Austria
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
GeneFinder
Hannover Medical School | Cairo, Egypt
Number of Samples Completed and Expected
Case Samples
0 Completed out of 420 Expected
Control Samples
0 Completed out of 450 Expected
Total Samples
0 Completed out of 870 Expected
GenePARKGR
University of Thessaly, Medical School | Volos, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 586 Expected
Control Samples
0 Completed out of 469 Expected
Total Samples
0 Completed out of 1,055 Expected
Genetic analysis in inherited neurological disorders
Garvan Institute of Medical Research | Sydney, Australia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Genetic study of PD and related movement disorders
Stellenbosch University | Cape Town, South Africa
Number of Samples Completed and Expected
Case Samples
0 Completed out of 730 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 730 Expected
Genetic Testing in Patients with Movement Disorders and PD
Chulalongkorn University | Bangkok, Thailand
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Genomes Project
University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Genotype-Phenotype Correlations in Nepalese PD Population
Tribhuvan University | Kathmandu, Nepal
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
Genotype-Phenotype Correlations in PD and Related Movement Disorders
University of Malaysia | Kuala Lumpur, Malaysia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
GP2 – Fundación Diagnosis
Fundación Diagnosis | Santiago, Chile
Number of Samples Completed and Expected
Case Samples
0 Completed out of 100 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 100 Expected
GP2 – Koc University
Koc University | Istanbul, Turkey
Number of Samples Completed and Expected
Case Samples
0 Completed out of 200 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 200 Expected
GP2 – Medical University of Lodz
Medical University of Lodz | Lodz, Poland
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
GP2 – Seoul National University Hospital
Seoul National University Hospital | Seoul, South Korea
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending
HIPDR
University of Miami | Miami, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 140 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 140 Expected
ICEBERG
Inserm, French Institute of Health and Medical Research | Paris, France
Number of Samples Completed and Expected
Case Samples
0 Completed out of 180 Expected
Control Samples
0 Completed out of 70 Expected
Total Samples
0 Completed out of 250 Expected
Request AMP® PD Data Set
As GP2 completes cohort genotyping, all data is shared through the secured AMP® PD platform. Register to request access to this data.
Submit a Cohort
If you would like to collaborate with GP2, reach out to submit a cohort or get more information on how to become a member.
Discover GP2 Members from Around the Globe
Explore the organizational members that make our research possible through their collaboration and contribution of samples and data.
